#BiologicsHQ Update: Pfizer’s Remicade (infliximab) biosimilar Ixifi was approved yesterday! See our list of #biosimilars approved in the US biologicshq.com/stats_entry/… #FDA
#BiologicsHQ update: Two new #biosimilars for breast cancer treatment Herceptin have been filed with the #FDA
biologicshq.com/stats_entry/…
#BiologicsHQ stat: #biosimilars #IPR petitions decline after sharp spike earlier this year biologicshq.com/stats_entry/… #FDA #Biologics
#BiologicsHQ update: There are currently 12 pending #FDA applications for #biosimilars biologicshq.com/stats_entry/…
#BiologicsHQ: Check out our latest "Spotlight On" featuring #patent lit and #IPR info for Adalimumab biologicshq.com/spotlight-on… #Biologics #FDA
1.#BiologicsHQ stat: Currently #biosimilars #IPRs have challenged over 860 claims in 31 #patents. biologicshq.com/stats_entry/…
#BiologicsHQ: There are 30 #biosimilars #patent #IPR petitions pending #USPTO institution decision. See more at biologicshq.com/.
#BiologicsHQ #IPR stats: 41% of #FDA #biologics #patent IPRs have been instituted - Learn more at biologicshq.com/stats_entry/… #CDER
#Biosimilars fact: Over 50 #patents concerning #CDER #drugs in #litigation. Search #biologics stats at biologicshq.com/biologicshq-…
#BiologicsHQ
#Biosimilars fact: There are 11 pending #FDA applications for #Biosimilars. Find more info at biologicshq.com/! #BiologicsHQ
